Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $4.2 million.

  • Solesence's Operating Expenses rose 4294.08% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 3640.98%. This contributed to the annual value of $11.1 million for FY2024, which is 277.02% down from last year.
  • As of Q3 2025, Solesence's Operating Expenses stood at $4.2 million, which was up 4294.08% from $4.0 million recorded in Q2 2025.
  • Solesence's Operating Expenses' 5-year high stood at $4.2 million during Q3 2025, with a 5-year trough of $1.5 million in Q4 2021.
  • In the last 5 years, Solesence's Operating Expenses had a median value of $2.8 million in 2023 and averaged $2.7 million.
  • In the last 5 years, Solesence's Operating Expenses plummeted by 3361.99% in 2021 and then soared by 9828.79% in 2022.
  • Quarter analysis of 5 years shows Solesence's Operating Expenses stood at $1.5 million in 2021, then soared by 91.89% to $2.8 million in 2022, then dropped by 15.88% to $2.4 million in 2023, then grew by 26.22% to $3.0 million in 2024, then skyrocketed by 38.88% to $4.2 million in 2025.
  • Its Operating Expenses stands at $4.2 million for Q3 2025, versus $4.0 million for Q2 2025 and $3.1 million for Q1 2025.